Abstract

Background and Aims : Nutraceuticals represent a new opportunity in reducing mild-moderate cholesterolemia, even in statin-intolerant patients. Lactobacillus plantarum (LP) strains CECT7527-CECT7528-CECT7529 (AB-LIFE), isolated from human intestine, demonstrated cholesterol-lowering properties both in animal and human studies.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call